Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ergobilt (ERGB) - Ergonomic Chairs -- Ignore unavailable to you. Want to Upgrade?

To: tonto who wrote (677)	1/31/1998 7:19:00 AM
From: CLEMENZA	Read Replies (1) \| Respond to of 900

Better times may lie ahead !

To: tonto who wrote (677)	1/31/1998 12:42:00 PM
From: Scott D. Hakala	Read Replies (1) \| Respond to of 900

Tonto, The support is simple. A stock trading at a price to leading P/E of 6.00 and with consistent historical sales and earnings growth and excellent prospects for future growth in sales and earnings is a rediculous buy. That buying opportunity has been created by persons attacking the Company relentlessly, attempting to manipulate the stock price and creating confusion that will only be cleared up as the Company moves into its next fiscal year and produces strong sales and earnings growth in the next fiscal year. Persons that have taken the time to really research the issues and discuss these issues with Hard Questions of ERGB management have decided that the Company is extremely underpriced. Tonto, You called me once before. Give me a call again.